Literature DB >> 12142024

The homeobox gene mbx is involved in eye and tectum development.

Atsuo Kawahara1, Chi-Bin Chien, Igor B Dawid.   

Abstract

The homeobox gene mbx is first activated at the end of gastrulation in zebrafish in the presumptive forebrain and midbrain region. During somitogenesis stages, the anterior expression of mbx, which partly overlaps the future eye field, gradually decreases, while midbrain expression intensifies and becomes restricted to the presumptive tectum. Knockdown of mbx expression by morpholino antisense oligonucleotides (mbx-MO) leads to a reduction in the size of the eyes and tectum. Expression domains of rx1 and pax6 in the eye field and of mab21l2 in the eye field and tectum anlage were reduced in size in mbx-MO-injected embryos by somitogenesis stages. Further, induction of islet1 and lim3 expression in the eye at 2 days postfertilization (dpf) was suppressed in mbx-MO-injected embryos. In mbx-MO-injected embryos at 2-5 dpf, the lamination of the eye was disorganized and the number of retinal axons was substantially reduced, but the few remaining axons navigated appropriately to the contralateral tectum. A chimeric protein composed of the Mbx DNA-binding domain and the VP16 activation domain affected eye and tectum development similarly to mbx-MO knockdown, suggesting that Mbx acts as a transcriptional repressor in the zebrafish embryo. Based on these data, we propose that the mbx homeobox gene is required for the development of the eyes and tectum.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142024     DOI: 10.1006/dbio.2002.0709

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  23 in total

1.  Neurogenesis in the sea urchin embryo is initiated uniquely in three domains.

Authors:  David R McClay; Esther Miranda; Stacy L Feinberg
Journal:  Development       Date:  2018-11-09       Impact factor: 6.868

2.  Genomic sequence and spatiotemporal expression comparison of zebrafish mbx1 and its paralog, mbx2.

Authors:  Lou Chang; Brian Khoo; Loksum Wong; Vincent Tropepe
Journal:  Dev Genes Evol       Date:  2006-05-30       Impact factor: 0.900

3.  Aberrant expression of genes necessary for neuronal development and Notch signaling in an epileptic mind bomb zebrafish.

Authors:  Gabriela A Hortopan; Scott C Baraban
Journal:  Dev Dyn       Date:  2011-06-17       Impact factor: 3.780

4.  Analysis of the retina in the zebrafish model.

Authors:  Andrei Avanesov; Jarema Malicki
Journal:  Methods Cell Biol       Date:  2010       Impact factor: 1.441

5.  Duplicate dmbx1 genes regulate progenitor cell cycle and differentiation during zebrafish midbrain and retinal development.

Authors:  Loksum Wong; Cameron J Weadick; Claire Kuo; Belinda S W Chang; Vincent Tropepe
Journal:  BMC Dev Biol       Date:  2010-09-22       Impact factor: 1.978

6.  Neonatal lethality, dwarfism, and abnormal brain development in Dmbx1 mutant mice.

Authors:  Akihira Ohtoshi; Richard R Behringer
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  Uncoupling nicotine mediated motoneuron axonal pathfinding errors and muscle degeneration in zebrafish.

Authors:  Lillian Welsh; Robert L Tanguay; Kurt R Svoboda
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-23       Impact factor: 4.219

8.  Ewing sarcoma fusion protein EWSR1/FLI1 interacts with EWSR1 leading to mitotic defects in zebrafish embryos and human cell lines.

Authors:  Lisa J Embree; Mizuki Azuma; Dennis D Hickstein
Journal:  Cancer Res       Date:  2009-05-05       Impact factor: 12.701

9.  Embryonic motor activity and implications for regulating motoneuron axonal pathfinding in zebrafish.

Authors:  Evdokia Menelaou; Erin E Husbands; Robin G Pollet; Christopher A Coutts; Declan W Ali; Kurt R Svoboda
Journal:  Eur J Neurosci       Date:  2008-09       Impact factor: 3.386

10.  Secondary motoneurons in juvenile and adult zebrafish: axonal pathfinding errors caused by embryonic nicotine exposure.

Authors:  Evdokia Menelaou; Kurt R Svoboda
Journal:  J Comp Neurol       Date:  2009-01-20       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.